GLP-2T is an FDA-approved dual GIP/GLP-1 receptor agonist from Eli Lilly, sold as Mounjaro (type 2 diabetes, 2022) and Zepbound (weight management, 2023; obstructive sleep apnea, 2024).
Tirzepatide + Retatrutide Prices
1 vendor · 0 with an issuer-verified COA · 10mg buy-in from $148.45 · checked
Where to buy Tirzepatide + Retatrutide: 1 vendor compared
1 of 1 vendors
| Vendor | Price | Updated | Actions |
|---|---|---|---|
| $148.45 | Oct 5, 2026 | Buy Tirzepatide + Retatrutide from Zen Aminos |
Tracked every day
Tirzepatide + Retatrutide price per mg, tracked daily
The five cheapest in-stock listings for Tirzepatide + Retatrutide on each collected day, and the vendors that most often held those places.
Five cheapest in-stock listings per day
- Cheapest$164.95
Vendors most often in the cheapest five
- Zen Aminos2 days$164.950.0%
Current market data
Tirzepatide + Retatrutide Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for Tirzepatide + Retatrutide is $148.45 from Zen Aminos. The median across vendors is $148.45.
- Lowest 10mg cost
- $148.45Zen Aminos
- Median 10mg cost
- $148.45One normalized offer per vendor
- Lowest package total
- $148.45Zen Aminos · package size may differ
- Public COA coverage
- 100%1 of 1 vendors
What the market shows
PeptidePrices found 1 in-stock listing from 1 vendor, checked through Oct 5, 2026. The lowest 10mg cost is 0% below the vendor median of $148.45; 0 vendors (0%) fall below that median. 1 of 1 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
What is Tirzepatide + Retatrutide? Research, safety, and status
Unlike GLP-3R (still investigational), GLP-2T is fully FDA-approved, as Mounjaro for type 2 diabetes, Zepbound for chronic weight management, and Zepbound for obstructive sleep apnea in adults with obesity. The clinical evidence base behind it is among the deepest of any peptide therapeutic.
Key research takeaways
It carries a boxed warning for thyroid C-cell tumors and is contraindicated in anyone with a personal/family history of medullary thyroid carcinoma or MEN 2.
Tirzepatide + Retatrutide at a glance
PeptidePrices safety rating
8/10 · FDA-approved (Mounjaro/Zepbound)
Mechanism
Research blend of the named components; compare total nominal mass and verify each component against the batch report.
Extensive Phase III data; GI side effects manageable; thyroid warning animal-only; strong efficacy Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Related pages